Lifestyle and Metabolic Health, Low-Grade to Clinically Elevated Albuminuria, and Cardiovascular-Renal Diseases

Read full text
Authors: Yi Ding, Qiuyu Cao, Xianglin Wu, Youjin Jiang, Xiaoran Li, Yu Xu, Min Xu, Tiange Wang, Yuhong Chen, Zhiyun Zhao, Jie Zheng, Shuangyuan Wang
+36 more Hong Lin, Xuejiang Gu, Li Yan, Miao Zhang, Zhengnan Gao, Lulu Chen, Tianshu Zeng, Ruying Hu, Zhen Ye, Xuefeng Yu, Gang Chen, Qing Su, Yiming Mu, Xulei Tang, Qin Wan, Guixia Wang, Guijun Qin, Zuojie Luo, Yingfen Qin, Li Chen, Xinguo Hou, Yanan Huo, Qiang Li, Hong Qiao, Yinfei Zhang, Chao Liu, Youmin Wang, Shengli Wu, Tao Yang, Huacong Deng, Jiajun Zhao, Weiqing Wang, Guang Ning, Jieli Lu, Mian Li, Yufang Bi
Cited by: 1
References: 46

Abstract

BACKGROUND: Albuminuria from low-grade to clinically elevated range confers cardiorenal risks. OBJECTIVES: The authors aimed to investigate the differential roles of lifestyle/metabolic factors in the association of fine-categorized and continuously measured urinary albumin-to-creatinine ratio (UACR) levels with cardiorenal outcomes. METHODS: A total of 82,509 participants from the China Cardiometabolic Disease and Cancer Cohort (4C) Study were included, with a median follow-up of 3.0 years. Outcomes included incident cardiovascular disease (CVD), incident CKD, their composite, along with surrogate markers. Lifestyle factors included tobacco use, alcohol use, diet, physical activity and sleep. Metabolic factors included diabetes, hypertension, abdominal obesity, and elevated low-density lipoprotein cholesterol. Cox proportional hazard models were used to calculate hazard ratios. RESULTS:

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Inflammatory Biomarkers in Disease Prognosis Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Journal / source
JACC Asia
Publisher
Elsevier BV
Volume
6
Issue
10
Pages
2186-2200
Publication date
1 August 2026
Language
EN